Aimed Alliance submitted a letter to the Kansas Legislature, urging the Committee on Financial Institutions and Insurance to evaluate the…
Aimed Alliance provided a letter of support for the passage of Washington Senate Bill 5064, which would establish an advisory…
Aimed Alliance provided feedback on Maryland’s Prescription Drug Affordability Board’s draft regulations, COMAR 14.01.0 and COMAR 14.01.05, which amend and…
On January 24, 2025, Aimed Alliance submitted a comment to the Virginia House Appropriations – Health and Human Resources Subcommittee,…
New data released by the National Community Pharmacists Association (NCPA) finds that roughly 30 percent of independent pharmacies have chosen…
In February 2025, Aimed Alliance submitted a comment on Washington Senate Bill 5353, which would require health carriers to provide…
Aimed Alliance provided comments on Maryland’s SB0357/HB0424, legislation that would enable the Maryland Prescription Drug Affordability Board (PDAB) to establish…
On November 8, 2024, Aimed Alliance submitted feedback to the Maryland Prescription Drug Affordability Board regarding its updated rules for…
On October 18, 2024, Aimed Alliance sent a letter to the Maryland Legislative Policy Committee, urging it to make major…
On October 16, 2024, Aimed Alliance submitted a comment to Colorado’s PDAB regarding proposed changes to its Drug Affordability Review…